首页> 美国卫生研究院文献>BMC Medical Research Methodology >Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design

【2h】

Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design

机译：调查员的影响在医疗实践中启动试验和行业赞助试验（影响）：理由和研究设计

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Research Impact Assessment

机译：研究影响评估

著录项

期刊名称 BMC Medical Research Methodology
作者
E. Nury; K. Bischoff; K. Wollmann; K. Nitschke; S. Lohner; M. Schumacher; G. Rücker; A. Blümle;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 15
原文格式 PDF
正文语种
中图分类医院、综合医院;中医院;
关键词

机译：随机对照试验;学习登记处;获取信息;循证医学;系统评论;临床指南;知识翻译;临床决策;调查员启动试验;工业赞助试验;

相似文献

外文文献
中文文献
专利

1. Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT) [J] . Blümle Anette, Wollmann Katharina, Bischoff Karin, BMC Medical Research Methodology . 2021,第1期

机译：调查员启动试验与行业赞助试验 - 将随机对照试验翻译成临床实践（影响）
2. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial [J] . de Waha Antoinette, Sandner Sigrid, von Scheidt Moritz, The American heart journal . 2016,第期

机译：随机，平行群，TiCagreloR的双盲研究与阿司匹林预防冠心动脉旁路移植手术患者的血管事件：CABG（TICAB）试验中TicagreloR的理由和设计：调查员启动的试验
3. Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design [J] . WoudstraP., GrundekenM.J., KraakR.P., The American heart journal . 2014,第2期

机译：Amsterdam Investigator-initiateD Absorb策略所有患者试验（AIDA试验）：一项临床评估，比较了ABSORB依维莫司洗脱生物可吸收血管支架策略与XIENCE系列（XIENCE PRIME或XIENCE Xpedition）依维莫司洗脱冠状动脉支架策略的疗效和性能连续性所有患者的冠状动脉病变的治疗：原理和研究设计
4. Tamoxifens Impact as a Preventive Agent in Clinical Practice and an Update on the STAR Trial [C] . D. Lawrence Wickerham International Society of Cancer Chemoprevention . 2003

机译：Tamoxifens在临床实践中的预防剂和明星试验的更新
5. Clinical trials driven by investigator-sponsors: GCP compliance with or without previous industry sponsorship [D] . Whalen, Ellen R. 2013

机译：研究者赞助者进行的临床试验：是否有先前的行业赞助都符合GCP
6. Impact of Obesity on Postoperative Outcomes following cardiac Surgery (The OPOS study): rationale and design of an investigator-initiated prospective study [O] . Christie Aguiar, Jeffrey MacLeod, Alexandra Yip, 2019

机译：肥胖对心脏手术后术后结果的影响（OPOS研究）：由研究人员发起的前瞻性研究的原理和设计
7. Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): Rationale and study design [O] . Edris Nury, Karin Bischoff, Katharina Wollmann, 2020

机译：调查员的影响在医疗实践中启动试验和行业赞助试验（影响）：理由和研究设计
8. Impact of Randomized Clinical Trials on Health Policy and Medical Practice [R] . 1983

机译：随机临床试验对卫生政策和医学实践的影响

Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design

摘要

著录项

相似文献

相关主题

期刊订阅